Paper Details

  1. Home
  2. Paper Details

Ranolazine for the suppression of ventricular arrhythmia: a case series.

Author: DaleRita A, HaigneyMark C, KrantzMori J, SchullerJoseph L, YeungEric

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.

Overview

Premature ventricular complexes (PVCs) and ventricular tachycardia (VT) are arrhythmias that can lead to serious health problems. This study examines the potential for ranolazine, a drug that blocks the late sodium current, to suppress ventricular arrhythmias.
Paper Details　
Original Abstract of the Article :
Premature ventricular complexes (PVCs) and ventricular tachycardia (VT) are associated with persistent symptoms and ventricular dysfunction. Approved medical therapies have undesirable side effects and proarrhythmic liability. Ranolazine is a novel antianginal that preferentially blocks the late sod...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6931933/

データ提供：米国国立医学図書館（NLM）

Ranolazine for Ventricular Arrhythmia: A Case Series

Ventricular arrhythmias, like sudden and unexpected sandstorms in the desert of the heart, can disrupt the smooth rhythm of the heart and pose serious health risks. This research explores the potential of ranolazine, a novel antianginal drug, for suppressing ventricular arrhythmias. The study presents a series of cases, carefully evaluating the effectiveness of ranolazine in patients with premature ventricular complexes (PVCs) and ventricular tachycardia (VT). It's like embarking on a journey through the desert of cardiovascular health, seeking a solution to a challenging condition.

Ranolazine: A Potential Solution for Ventricular Arrhythmias

The researchers observed positive results in some cases, demonstrating the potential of ranolazine to suppress ventricular arrhythmias. While further research is needed to establish the efficacy and safety of ranolazine for this specific purpose, the initial findings offer hope for patients struggling with these arrhythmias.

Protecting the Heart: A New Hope

This research suggests that ranolazine could offer a new approach to managing ventricular arrhythmias, potentially reducing the burden of these potentially life-threatening conditions.

Dr.Camel's Conclusion

This research offers a glimpse into a potential oasis within the desert of ventricular arrhythmias, highlighting the possible benefits of ranolazine for suppressing these conditions. The study serves as a reminder that the quest for effective treatments for cardiovascular diseases continues, and promising new solutions may emerge from unexpected directions.

Date :
  1. Date Completed 2015-04-15
  2. Date Revised 2021-10-21
Further Info :

Pubmed ID

24533675

DOI: Digital Object Identifier

PMC6931933

Related Literature

Article Analysis
・Side Effects of ranolazine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.